Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$493K Buy
1,361
+1,179
+648% +$404K 0.01% 328
2026
Q1
$64K Buy
+182
New +$64.9K ﹤0.01% 397
2025
Q4
– Sell
-810
Closed -$228K – 473
2025
Q3
$228K Buy
810
+10
+1% +$2.9K ﹤0.01% 404
2025
Q2
$222K Buy
+800
New +$227K ﹤0.01% 364

Other funds holding AMGN

Groupe la Francaise's AMGN Position: Q2 2026 in Review

Groupe la Francaise increased its Amgen (AMGN) stake by 648% in Q2 2026, buying an estimated $404K and bringing the position to 1,361 shares worth $493K. The position accounts for 0.01% of the portfolio, ranked #328.

Groupe la Francaise first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Groupe la Francaise held 1,361 shares of Amgen worth $493K as of Q2 2026.
  • Groupe la Francaise bought 1,179 Amgen shares in Q2 2026, an estimated $404K.
  • Amgen made up 0.01% of Groupe la Francaise's portfolio in Q2 2026, its #328 holding.
  • Groupe la Francaise first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.